Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evidence that clearance of hepatitis C virus RNA after alpha-interferon therapy in dialysis patients is sustained after renal transplantation.

Journal of the American Society of Nephrology : JASN - 1 Aug 2003

Kamar Nassim, Toupance Olivier, Buchler Matthias, Sandres-Saune Karine, Izopet Jacques, Durand Dominique, Rostaing Lionel

Abstract excerpt

To date, there is no available treatment of hepatitis C virus (HCV) infection after renal transplantation (RT). Among 55 anti-HCV-positive/HCV RNA-positive hemodialysis patients who were treated with IFN-alpha (9 MU/wk during 6 or 12 mo), 21 of them (38%) had a sustained virologic response. Of these, 16 (76%) underwent RT 38 mo (range, 2 to 57 mo) after alpha-IFN therapy. There were 13 men and 3 women aged 46 yr...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cyclosporine
Share to Hepatitis C

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunosuppressive Agents

Share to Interferon-alpha

Share to Kidney Transplantation

Share to Leukocytes, Mononuclear

Share to Recurrence

Share to Renal Dialysis

Source

Identifiers

PMID: 12874463
DOI: 10.1097/01.asn.0000079613.81511.3c

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evidence that clearance of hepatitis C virus RNA after alpha-interferon therapy in dialysis patients is sustained after renal transplantation.PMID 12874463Read ↗

[HCV RNA clearance after treatment with interferon-alpha in chronic hemodialysis patients with or without coinfection by HGV/HGBV-C].Semantic proximity Read ↗

Virological and histological responses to one year alpha-interferon-2a in hemodialyzed patients with chronic hepatitis C.Semantic proximity Read ↗

Hepatitis C Virus Eradication in Kidney Transplant Recipients: A Single-Center Experience in Portugal.Semantic proximity Read ↗

The role of transfusion-transmitted virus in patients undergoing hemodialysis.Semantic proximity Read ↗

Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy.Semantic proximity Read ↗

Efficacy and tolerability of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C.Semantic proximity Read ↗

Long-term outcome of recombinant INF-alpha treatment of chronic hepatitis C in kidney transplant recipients.Semantic proximity Read ↗

Preliminary results of treatment with pegylated interferon alpha 2A for chronic hepatitis C virus in kidney transplant candidates on hemodialysis.Semantic proximity Read ↗

Virological features of hepatitis C virus infection in hemodialysis patients.Semantic proximity Read ↗

Long-term ribavirin therapy in hepatitis C virus-positive renal transplant patients: effects on renal function and liver histology.Semantic proximity Read ↗

Efficacy and tolerability of low-dose interferon-α in hemodialysis patients with chronic hepatitis C virus infection.Semantic proximity Read ↗

Hepatitis C virus infection in renal failure patients in the absence of anti-hepatitis C virus antibodies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.